secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001477449-25-000063
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc shareholders approve 6.85M share increase for incentive plan; say-on-pay passes with 26.6% against
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2023 Incentive Award Plan, increasing authorized shares by 6,850,000.
- All nine director nominees elected; David B. Snow Jr. received 19.9M against (23.9% against) and Kenneth Paulus received 10.9M against (13.1% against).
- Advisory vote on executive compensation passed: 61.2M for, 22.2M against (26.6% against).
- Ratification of Ernst & Young as independent auditor for FY2025 approved with 119.9M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744925000063/0001477449-25-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744925000063/tdoc-20250522.htm
  HTML page:      https://secwatch.observer/filing/0001477449-25-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer